排序方式: 共有6条查询结果,搜索用时 15 毫秒
1
1.
YOSHIKAZU MURAWAKI YUJIRO IKUTA YUUKO NISHIMURA MASAHIKO KODA HIRONAKA KAWASAKI 《Journal of gastroenterology and hepatology》1996,11(5):443-450
In order to elucidate collagen metabolism in hepatocellular carcinoma (HCC) tissue, we compared levels of different potential markers of collagen metabolism and plasma transforming growth factor-β1 in patients with HCC and in patients with liver cirrhosis. Serum levels of prolyl hydroxylase and the tissue inhibitor of metalloproteinase-1 in patients with HCC were significantly higher than those in patients with liver cirrhosis and increased with the size of the HCC tumour, whereas the serum levels of procollagen type III propeptide and type IV collagen 7S domain were similar in the two groups. In HCC, the increased plasma transforming growth factor-β1 levels were closely correlated with serum levels of prolyl hydroxylase and the tissue inhibitor of metalloproteinase-1. These findings suggest that, in HCC tissue, the intracellular biosynthesis of collagen is enhanced, whereas the secretion of procollagen is disturbed and the degradation of collagen is suppressed by the excess production of the tissue inhibitor of metalloproteinase-1. The results also suggest that plasma transforming growth factor-β1 plays an important role in the altered metabolism of collagen in HCC. 相似文献
2.
3.
TAKESHI HOUJOU KOUSUKE NAKANO OSAMU IKE HIROMI WADA SIGEKI HITOMI YUUKO SHINMI NORIYUKI DANNO YUKAKO YOSHIKAWA KANJI TAKADA 《The Journal of pharmacy and pharmacology》1996,48(5):474-478
An oral sustained-release cisplatin preparation was prepared by combining microporous water-insoluble pharmaceutical polymer, ethylcellulose, a membrane and a gel-forming polymer, poly(acrylic) acid (Carbopol). As cisplatin is an extremely hydrophilic and small compound, it was difficult to control the release rate solely by the micropores on the ethylcellulose capsule. To retain cisplatin within the capsule, gel-forming polymer was formulated inside the capsule. The release rate of cisplatin was dependent both on the number of micropores of the capsule and the formulated amount of Carbopol. The number of micropores ranged from 20 and 30 to 60, and the formulated amount of Carbopol varied from 15 to 100 mg. In-vitro release experiments suggested that the release rate decreased as the formulated amount of Carbopol increased when the pore number was 60 and 30. However, when pore number was decreased to 20, the effect of the amount of Carbopol was not clearly observed. In the in-vivo study using rabbits, the sustained-release cisplatin capsule was evaluated in comparison with solution after oral administration of 20 mg drug. With the pore number of 60, Cmax was 0.46 ± 0.02 μg mL?1 at 4 h and thereafter serum concentrations declined rapidly. When the pore number was 30, serum cisplatin level-time profiles showed long-acting patterns and AUC was reversely correlated with the formulated amount of Carbopol. Cmax and tmax were 0.41 ± 0.02 μg mL?1 and 3.33 ± 0.88 h, respectively and 0.23 ± 0.01 μg mL?1 was obtained at 24 h after oral administration of capsule having 30 pores and 15 mg of Carbopol. We conclude that the possibility of developing an oral sustained-release cisplatin preparation is feasible. 相似文献
4.
Clinical significance of serum hyaluronan in patients with chronic viral liver disease 总被引:14,自引:0,他引:14
YOSHIKAZU MURAWAKI YUJIRO IKUTA MASAHIKO KODA YUUKO NISHIMURA HIRONAKA KAWASAKI 《Journal of gastroenterology and hepatology》1996,11(5):459-465
In order to elucidate the clinical significance of serum hyaluronan in chronic viral hepatitis, serum hyaluronan concentrations were measured using a sandwich enzyme binding assay in 115 patients with chronic viral hepatitis. These findings were examined in relation to the results of laboratory liver tests, levels of serum markers for fibrosis and liver histological findings. Serum hyaluronan levels increased with the progress of liver disease, particularly in liver cirrhosis. There were no significant differences in serum hyaluronan levels among the cirrhotic patients according to Child's grade. Multivariate analysis showed that the significant independent predictors of serum hyaluronan were serum aspartate aminotransferase (P= 0.020), serum alanine aminotransferase (P= 0.008), serum cholinesterase (P< 0.001), particularly serum type IV collagen 7S domain (P< 0.0001), and the histological degree of liver fibrosis (P< 0.0001). These findings suggest that elevated serum hyaluronan levels are closely related to the severity of liver fibrosis. We assessed the predictive value of serum hyaluronan in differentiating cirrhosis from chronic hepatitis, constructing receiver operating curves; we found that serum hyaluronan was a better test for diagnosing cirrhosis than serum type IV collagen 7S domain and laboratory liver tests. 相似文献
5.
6.
YOSHIKAZU MURAWAKI YUUKO NISHIMURA YUJIRO IKUTA YOUKO IDOBE YUKISATO KITAMURA HIRONAKA KAWASAKI 《Journal of gastroenterology and hepatology》1998,13(7):680-684
Transforming growth factor (TGF)-β1 is an important cytokine involved in the pathobiology of tissue fibrosis through its stimulation of the production of, and inhibition of the degradation of, extracellular matrix proteins. We examined the clinical usefulness of plasma TGF-β1 concentration as a marker of fibrogenesis in patients with chronic viral hepatitis. Thirty-five patients, 11 with minimal chronic hepatitis, 14 with mild chronic hepatitis and 10 with moderate chronic hepatitis and 20 healthy subjects were studied. Transforming growth factor-β1 concentrations in platelet-poor plasma were measured with a TGF-β1 enzyme-linked immunosorbent assay system kit after acid-ethanol extraction. Plasma TGF-β1 levels were significantly elevated in patients with mild and moderate chronic hepatitis, but not in those with minimal chronic hepatitis, compared with the levels in the controls. Plasma TGF-β1 levels were increased in parallel with the histological degree of necroinflammation and of liver fibrosis. Plasma TGF-β1 levels were positively correlated with blood levels of procollagen type III N-peptide, and 7S fragment and central triple-helix of type IV collagen. These results suggest that plasma TGF-β1 level is a useful marker in assessing the situation of liver active fibrogenesis in patients with chronic viral hepatitis. 相似文献
1